MUMBAI: Makers Lab Ltd, the research and development (R&D) arm of IT services provider, Tech Mahindra Ltd, has leveraged artificial intelligence (AI) to find potential therapeutic drugs for treatment of covid-19, commonly know as the novel coronavirus.
Tech Mahindra is also collaborating with bio-scientists for plausible therapeutic drugs and research laboratories to synthesise and test these compounds.
Indian IT firms, with their early investments in AI, have been using their computational resources to facilitate various aspects of covid-19 drug development and research.
Recently, Tata Consultancy Services Ltd's (TCS) innovation lab used a methodology to identify 31 drug molecules for potential clinical trials.